Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

2
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
2
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

2
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
2
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Maternal Cardiac Disease and Congenital Heart Disease Risk in Offspring.

JAMA network open·2026
Same author

BMPR2 affects valve development via ECM-receptor interaction in zebrafish.

Frontiers in cell and developmental biology·2026
Same author

Artificial Intelligence-powered tiered early warning framework addressing high false alarm rates for in-hospital mortality prediction.

NPJ digital medicine·2026
Same author

Employment of the Ascending Aortic Volume as a Predictor of Adverse Outcomes in Patients With Bicuspid Aortic Valve Disease.

Reviews in cardiovascular medicine·2026
Same author

Reply to the Letter to the Editor "Sex imbalance in a large Fontan cohort: Biological reality or marker of inequitable care?"

Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology·2026
Same author

Widening effect of SICM topography measurement based on electrolyte concentration gradient with dual-barrel pipette.

Micron (Oxford, England : 1993)·2026

Related Experiment Video

Updated: Jun 9, 2025

Isolation and Physiological Analysis of Mouse Cardiomyocytes
11:02

Isolation and Physiological Analysis of Mouse Cardiomyocytes

Published on: September 7, 2014

23.0K

Cardiomyopathy: pathogenesis and therapeutic interventions.

Shitong Huang1, Jiaxin Li1, Qiuying Li1

  • 1Department of Cardiac Surgical Intensive Care Unit Guangdong Cardiovascular Institute Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences) Southern Medical University Guangzhou China.

Medcomm
|October 28, 2024
PubMed
Summary

Cardiomyopathy involves heart muscle damage from genetic or environmental causes. Gene therapy targeting specific genes offers a promising, precise treatment approach for these diverse heart conditions.

Keywords:
cardiomyopathydisease‐causing genegene therapypathogenesispersonalized medicinetherapeutic interventions

More Related Videos

Isolation and Characterization of Cardiac Mesenchymal Stromal Cells from Endomyocardial Bioptic Samples of Arrhythmogenic Cardiomyopathy Patients
09:16

Isolation and Characterization of Cardiac Mesenchymal Stromal Cells from Endomyocardial Bioptic Samples of Arrhythmogenic Cardiomyopathy Patients

Published on: February 28, 2018

7.7K
Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model
07:50

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model

Published on: September 3, 2020

4.6K

Related Experiment Videos

Last Updated: Jun 9, 2025

Isolation and Physiological Analysis of Mouse Cardiomyocytes
11:02

Isolation and Physiological Analysis of Mouse Cardiomyocytes

Published on: September 7, 2014

23.0K
Isolation and Characterization of Cardiac Mesenchymal Stromal Cells from Endomyocardial Bioptic Samples of Arrhythmogenic Cardiomyopathy Patients
09:16

Isolation and Characterization of Cardiac Mesenchymal Stromal Cells from Endomyocardial Bioptic Samples of Arrhythmogenic Cardiomyopathy Patients

Published on: February 28, 2018

7.7K
Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model
07:50

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model

Published on: September 3, 2020

4.6K

Area of Science:

  • Cardiology and Genetics
  • Molecular and Cellular Biology
  • Translational Medicine

Background:

  • Cardiomyopathy encompasses myocardial diseases stemming from diverse etiologies, including genetic mutations and systemic disorders.
  • Understanding the molecular and cellular mechanisms underlying cardiomyopathy is crucial for developing effective treatments.
  • Current therapies include pharmaceuticals, mechanical support, and heart transplantation, with gene and cell therapies showing emerging potential.

Purpose of the Study:

  • To provide an in-depth analysis of the pathogenesis of various cardiomyopathies.
  • To highlight the molecular and cellular mechanisms involved in cardiomyopathy development and progression.
  • To review current and emerging therapeutic interventions, with a focus on gene therapy.

Main Methods:

  • Literature review of current research on cardiomyopathy pathogenesis.
  • Analysis of molecular and cellular mechanisms contributing to disease development.
  • Evaluation of existing and novel therapeutic strategies, including gene therapy.

Main Results:

  • Diverse etiologies contribute to cardiomyopathy, involving genetic mutations, environmental factors, and metabolic disorders.
  • Significant progress has been made in identifying genes associated with cardiomyopathies.
  • Gene therapy, particularly approaches targeting causal genes, demonstrates considerable therapeutic promise.

Conclusions:

  • Targeting specific causal genes offers a precise and potentially advantageous therapeutic strategy for cardiomyopathies.
  • Advancements in gene and cell therapy are revolutionizing treatment options for heart muscle diseases.
  • Continued research into pathogenesis and therapeutic interventions is vital for improving patient outcomes in cardiomyopathy.